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Summary
 
Recombinant HLA-A2, HLA-B8, or HLA-B53 heavy chain produced in 
 
Escherichia coli
 
 was
combined with recombinant 
 
b
 
2
 
-microglobulin (
 
b
 
2
 
m) and a pool of randomly synthesised non-
amer peptides. This mixture was allowed to refold to form stable major histocompatability
complex (MHC) class I complexes, which were then purified by gel filtration chromatography.
The peptides bound to the MHC class I molecules were subsequently eluted and sequenced as
a pool. Peptide binding motifs for these three MHC class I molecules were derived and com-
pared with previously described motifs derived from analysis of naturally processed peptides
eluted from the surface of cells. This comparison indicated that the peptides bound by the re-
combinant MHC class I molecules showed a similar motif to naturally processed and presented
peptides, with the exception of the peptide COOH terminus. Whereas the motifs derived
from naturally processed peptides eluted from HLA-A2 and HLA-B8 indicated a strong prefer-
ence for hydrophobic amino acids at the COOH terminus, this preference was not observed in
our studies. We propose that this difference reflects the effects of processing or transport on the
peptide repertoire available for binding to MHC class I molecules in vivo.
 
T
 
he MHC class I molecule consists of a variable heavy
chain noncovalently associated with an invariant 
 
b
 
2
 
-
microglobulin (
 
b
 
2
 
m) molecule and a short 8–10 amino acid
peptide. Studies of the crystal structure of MHC class I
molecules have shown that the peptide lies in a peptide-
binding groove of the MHC molecule and interacts with it
via a number of peptide binding pockets (1). These pockets
accommodate specific residues of the peptide and may al-
low only one or a few closely related amino acids to bind at
these positions. Studies of the peptide binding specificity of
different MHC molecules have utilized analysis of peptides
naturally bound to MHC class I molecules on the cell sur-
face. Sequencing of these peptides has revealed require-
ments for specific amino acids at particular positions of the
peptide (2). Motifs for HLA-A2, HLA-B8, and HLA-B53
have been derived by this method (3).
The peptides presented by MHC class I molecules are
derived from intracellular sources. Endogenous proteins or
proteins derived from viruses or intracellular pathogens are
degraded within the cytoplasm to form short peptides. These
peptides are then transported into the endoplasmic reticu-
lum by the transporter associated with antigen processing
(TAP) molecule, where they encounter MHC class I heavy
chain and 
 
b
 
2
 
m and promote assembly of these into a trimo-
lecular complex. Therefore, peptide binding motifs of MHC
class I molecules that are derived from analysis of peptides
eluted from the cell surface include information on not only
what has been selected by the MHC class I molecule, but
also on what peptides have been made available to the class
I molecule by the processing machinery of the cell and the
peptide transporter. Therefore, it is important to determine
the relative contributions of these factors to the observed
motifs. We have used a method that involves assembly of
the MHC class I molecule in the absence of peptide pro-
cessing and transport, and therefore measures only the
specificity of the class I molecule itself. By comparison of
peptide binding motifs derived from the two methods, we
provide information on the possible contribution of selec-
tive transport or processing to the peptide binding motifs
observed within eluted peptides.
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Materials and Methods
 
Random Peptide Library.
 
Peptides were synthesized manually
using standard fmoc chemistry. Equimolar amounts of each of the
naturally occurring amino acids was used to a total of 10-fold mo-
lar excess. Cysteine was not included in this mix and arginine was
used at 1.5
 
3
 
 molar concentration to compensate for previously
observed low incorporation of this amino acid (4). The random-
ness of the peptide mixture was then analyzed by HPLC and la-
ser-desorption time of flight mass spectrometry.
 
Assembly and Purification of MHC Class I Complexes.
 
HLA-B53
and HLA-B8 were produced using vectors pGMT7B53HIS (5)
and pGMT7B8, respectively. HLA-A2 and 
 
b
 
2
 
m were produced
using the vectors pHN1A2 and pHN1
 
b
 
2m, respectively (a gift
from D. Garboczi, Harvard University, Cambridge, MA). HLA-
B53 and HLA-A2 were refolded with a random mix of peptides
using a dilutional method as previously described (6). In brief,
 
z
 
30 mg of random peptide pool was dissolved in a small volume
of 8 M urea and added to a solution of 1 
 
m
 
M heavy chain, 2 
 
m
 
M
 
b
 
2
 
m in refolding buffer (0.4 M 
 
L
 
-arginine, 0.1 M Tris [pH 
 
5
 
7.5], 2 
 
m
 
M EDTA, 5 mM reduced glutathione, 0.5 mM oxidized
glutathione, 0.5 mM PMSF). After incubation for 36–48 h at
4
 
8
 
C, the solution was concentrated and the refolded complex pu-
rified by gel filtration.
HLA-B8 was refolded using a dialysis method of refolding. In
brief, peptide, 
 
b
 
2
 
m, and heavy chain were mixed with 20 mM
Tris (pH 
 
5
 
 7.5) and 150 mM NaCl and then dialysed against re-
folding buffer. Additional heavy chain was added during incuba-
tion at 4
 
8
 
C for 48 h, then the solution was concentrated and the
refolded complex purified by gel filtration. In both methods, ran-
dom peptides were used at a final concentration of 
 
z
 
200-fold
molar excess over heavy chain in the refolding reaction. Self-pep-
tides from HLA-B53 were purified using a W6-32 affinity col-
umn as previously described (7).
 
Peptide Elution and Sequencing.
 
Bound peptides were eluted
from the MHC class I molecules as previously described (7). In
brief, MHC class I–peptide complexes were first concentrated on
a Centricon-3 microconcentrator (Amicon, Beverly, MA) before
the addition of 0.1% trifluoroacetic acid. The eluate was collected
and separated by HPLC before sequencing with an Applied Bio-
systems 473A protein sequencer (Applied Biosystems, Foster
City, CA). Samples of the random peptide library were also se-
quenced. Individual self-peptides eluted from affinity-purified
HLA-B53 were sequenced as previously described (8).
 
Results and Discussion
 
Analysis of the random peptide library by HPLC and la-
ser desorption-mass spectrometry showed that the library
was a homogeneous mix of peptides without any obvious
peaks of abundant peptides and conformed to the mass
range expected for nonamer peptides. Refolding of MHC
class I molecules with the random peptide mixture resulted
in the formation of stable complexes of heavy chain, pep-
tide, and 
 
b
 
2
 
m, which migrated at the correct mass using gel
filtration. A final concentration and wash step before pep-
Figure 1. Results of pool sequencing of peptides bound to recombinant HLA class I molecules. The yield of each amino acid (indicated by single letter
code) for each position of the peptide is shown for HLA-A2, HLA-B8, and HLA-B53. Positions where the yield of amino acid is 150% greater compared
with the previous cycle are underlined. 
369
 
Davenport et al. Brief Definitive Report
 
tide elution ensured that only peptides that formed com-
plexes stable enough to remain associated during these pro-
cedures were analyzed. Peptides were eluted from 
 
z
 
500
 
m
 
g of MHC class I. The results of pool sequencing of these
peptides and of the random peptide library showed that
while there were no significant enrichments for any amino
acids in the random library, such enrichments were found
in the MHC class I–associated pool. Positions where the
yield of a particular amino acid was increased to 150% or
more of the previous cycle were considered significant
(Fig. 1) (2). The motif identified using this method could
be compared with that identified by previous studies (Fig.
2). It can be seen that although the motifs were not identical,
the same anchor residues were observed by both methods
with the exception of the COOH-terminal hydrophobic
anchor previously observed in studies of HLA-A2 and
HLA-B8. In addition, in some cases in which enrichment
for anchor residues did not reach the 150% level, the same
patterns of enrichment were seen for both the naturally
bound peptides and the peptides bound by the recombi-
nant class I. It is also interesting that the strength of motifs
for different MHC class I alleles is conserved using both
methods, so that, for example, whereas HLA-A2 shows
strong enrichment for several possible minor anchors in
both pool sequences, HLA-B53 shows a relatively weak
proline anchor at position 2 using both methods (Fig. 2). In
addition, whereas analysis of four individual self-peptides
eluted from HLA-B53 and three T cell epitopes suggests a
preference for hydrophobic COOH termini (Fig. 3), this
was not observed in the results from pool sequencing. Thus
the amino acid preferences observed from pool sequencing
of HLA-B53 seem somehow less strong than those of, for
example, HLA-A2.
Previous studies of the peptide binding motifs of MHC
class I molecules have indicated that most HLA class I alleles
show a preference for a hydrophobic COOH-terminal
amino acid, with a small number favoring a positive charge
at this position (reviewed in reference 3). The majority of
these motifs are derived from analysis of the peptides bound
to MHC class I on the surface of B cells and thus reflect
both the specificity of the MHC class I molecule itself and
the effects of processing and transport. Direct binding of
synthetic peptides to MHC class I has also been used to
study the peptide binding specificity of these molecules.
Although a number of methods have been used (reviewed
in reference 3), it is difficult to reflect the dynamic interac-
tions of MHC and peptide using single peptides. The num-
ber of MHC peptide complexes on the cell surface will be
determined both by the ability of peptides to compete for
binding and also by the stability of the subsequent complex.
Parker and colleagues (9) have described experiments in
which they measured the stability of complexes formed be-
tween recombinant HLA-A2 and synthetic peptides. Inter-
Figure 2. Comparison of the peptide binding motifs for HLA-A2,
HLA-B8, and HLA-B53 derived by different methods. Motifs are indi-
cated according to the convention established by Falk et al. (2), namely,
dominant or strong anchor residues are indicated in bold type, and listed
vertically in order of descending importance. It should be noted that dif-
ferent criteria were used to assign anchors in some studies, particularly
when individual peptide as opposed to pool sequences were analyzed.
Hø, hydrophobic residue.
Figure 3. Sequences of individual self-peptides eluted from HLA-B53
and sequenced using tandem mass spectrometry. The isobaric residues
isoleucine and leucine could not be distinguished in the unknown pep-
tide. The sequences of three known HLA-B53 T cell epitopes are shown. 
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estingly, when the requirements of the peptide COOH
terminus were analyzed, these did not conform with the
expected restrictions.
The motifs observed in this study differ from those pre-
viously reported because they show no preference for a
COOH-terminal hydrophobic or positive charge. A trivial
explanation for this would be that the solutions and the
temperature at which binding was carried out may interfere
somehow with peptide–MHC interactions. However, since
preferences for both hydrophobic and other peptide an-
chors are conserved elsewhere in the motifs, this seems un-
likely. One simple mechanism to explain the observed dif-
ferences in peptide COOH termini is that naturally processed
peptides are subject to selection for transport into the endo-
plasmic reticulum by the TAP transporter, whereas our
random mixture is not. Studies of the substrate specificity
of the TAP protein in human, mouse, and rat have sug-
gested that whereas the rat TAP2
 
u
 
 and murine TAP were
highly selective for hydrophobic or aromatic COOH ter-
mini, the human TAP and the rat TAP2
 
a
 
 transporters were
only weakly selective for hydrophobic or positive charge
and against negative charge (10). Therefore, this bias would
tend to favor hydrophobic COOH termini in most MHC
class I alleles. Those MHC class I molecules that appear to
exhibit a preference for positively charged COOH termini
instead may simply be those which are less able to tolerate
hydrophobic COOH termini and thus bind the next most
abundant species, those with positively charged COOH ter-
mini. However, analysis of HLA-A2-associated peptides in
a mutant cell line lacking the TAP transporter suggests that
the preference for a hydrophobic COOH terminus is still
observed (11). Therefore, it is likely that other mechanisms
of peptide processing may act independently of or synergis-
tically with the TAP transporter to affect the COOH terminus
of the peptides. Experiments to determine the alterations in
substrate specificity conferred by the MHC-encoded LMP2
and LMP7 subunits of the proteasome have suggested that
the presence of these subunits enhances proteolysis after
hydrophobic and positively charged amino acids and de-
creases proteolysis after negatively charged amino acids (12,
13). In addition, we cannot exclude the possibility that
other processes involved in the generation and assembly of
MHC–peptide complexes, such as the involvement of mo-
lecular chaperones, may also act to bias the repertoire of
peptides available for binding to MHC class I.
The preference of both the putative proteolytic enzymes
and transporter molecules involved in class I processing for
hydrophobic or positively charged COOH termini of pep-
tides appears to accord with the observation that most
MHC class I motifs have hydrophobic COOH termini,
and the few that do not have positively charged COOH-
termini. This has been interpreted as suggesting that the an-
tigen processing machinery has evolved to supply the
MHC class I molecule with peptides optimal for binding.
However, because most MHC class I motifs are derived from
the analysis of peptides eluted from MHC class I molecules
on the cell surface, these motifs include the effects of both
antigen processing and MHC binding. Therefore, we favor
an alternate explanation for the observed preference for hy-
drophobic or positively charged COOH termini in MHC
class I motifs, namely that this is largely an effect of process-
ing and that in the absence of such processing this prefer-
ence is not found.
This observation does not affect the use of currently
available MHC class I motifs in the prediction of T cell
epitopes, since a hydrophobic COOH terminus will still be
required for natural processing and presentation of antigens.
On the other hand, these observations necessitate a reeval-
uation of the role of processing in the selection of peptides
for binding to MHC class I. A preference for COOH-ter-
minal hydrophobic residues for both the processing ma-
chinery and class I molecules would imply that the system
had evolved to optimize peptide delivery to class I. If class I
does not select for hydrophobic COOH termini in the ab-
sence of processing, then it would seem that the selection
for COOH-terminal hydrophobic anchors, in fact, acts to
restrict the repertoire of peptides available to bind MHC
class I. Although this may seem counterproductive, a pre-
cedent for such a limitation of peptides is already known.
The TAP transporter of human, mouse, and rat appears to
be a poor transporter of peptides with proline at positions 2
and 3 (14). However, a number of HLA-B alleles (includ-
ing HLA-B53) appear to bind a proline anchor at position 2
of the peptide. Thus, it would seem that either the selectiv-
ity of the transporter is acting to reduce the number of
peptides available to bind these, or that there is some ad-
vantage in longer peptides being transported and then
cleaved to generate the MHC binding peptide within the
endoplasmic reticulum. If the former is the case one can
only speculate as to the possible benefits to the host of re-
ducing the repertoire of endogenous peptides presented on
MHC class I. However, it is possible that this acts to de-
crease the effective hole in the T cell repertoire caused by
negative selection of T cells in the thymus.
The results of this work demonstrate that recombinant
MHC class I molecules produced in 
 
E. coli
 
 retain their pep-
tide specificity during refolding with peptide and 
 
b
 
2
 
m mol-
ecules in vitro. In addition, the observed differences be-
tween the peptide binding motifs derived from naturally
processed peptides and peptides bound to MHC class I in vi-
tro suggest that peptide processing and transport play a dom-
inant role in determining which peptides will ultimately be
presented in association with MHC class I.
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